Euroopa Liit - islandi - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - guanfacín hýdróklóríð - attention deficit disorder með ofvirkni - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv verður að vera notað sem hluti af alhliða kynlÍf meðferð áætlun, venjulega þar á meðal sálfræðilega, mennta og félagslega mælist.

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

mundipharma a/s - povidonum iodinatum inn - baðlyf - 75 mg/g

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

mundipharma a/s - povidone, iodinated - húðlausn - 100 mg/ml

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

mundipharma a/s - povidone, iodinated - húðlausn - 100. mg/ml

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

mundipharma a/s - povidone, iodinated - húðvökvi - 100 mg/ml

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - carvedilolum inn - tafla - 3,125 mg

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - carvedilolum inn - tafla - 6,25 mg

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - carvedilolum inn - tafla - 25 mg

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf. - bisoprololum fúmarat - filmuhúðuð tafla - 10 mg

Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf. - bisoprololum fúmarat - filmuhúðuð tafla - 5 mg